Yüklüyor......
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
BACKGROUND: Abiraterone acetate (abiraterone) prolongs overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC). This study's objective was to retrospectively identify factors associated with prostate-specific antigen (PSA) response to abiraterone and valid...
Kaydedildi:
| Yayımlandı: | Ann Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4433513/ https://ncbi.nlm.nih.gov/pubmed/24458472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt581 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|